0.93
price down icon2.99%   -0.0287
after-market Dopo l'orario di chiusura: .98 0.05 +5.38%
loading
Precedente Chiudi:
$0.9587
Aprire:
$0.95
Volume 24 ore:
155.10K
Relative Volume:
0.89
Capitalizzazione di mercato:
$73.47M
Reddito:
-
Utile/perdita netta:
$-20.59M
Rapporto P/E:
-2.7778
EPS:
-0.3348
Flusso di cassa netto:
$-17.99M
1 W Prestazione:
-1.59%
1M Prestazione:
-2.91%
6M Prestazione:
-10.58%
1 anno Prestazione:
-54.41%
Intervallo 1D:
Value
$0.928
$0.9765
Intervallo di 1 settimana:
Value
$0.9201
$0.9912
Portata 52W:
Value
$0.85
$2.30

Oncolytics Biotech Inc Stock (ONCY) Company Profile

Name
Nome
Oncolytics Biotech Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
27
Name
Cinguettio
@oncolytics
Name
Prossima data di guadagno
2024-08-01
Name
Ultimi documenti SEC
Name
ONCY's Discussions on Twitter

Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-10-06 Iniziato Maxim Group Buy
2021-02-17 Iniziato H.C. Wainwright Buy

Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie

pulisher
Sep 17, 2024

Oncolytics Biotech (NASDAQ:ONCY) Stock Price Down 0.7% - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Oncolytics Biotech (NASDAQ:ONCY) Trading Down 0.7% - MarketBeat

Sep 17, 2024
pulisher
Sep 07, 2024

Oncolytics Biotech Engages Investors at Key Conferences - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

Oncolytics Biotech Inc - Baystreet.ca

Sep 06, 2024
pulisher
Sep 06, 2024

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September - IT News Online

Sep 06, 2024
pulisher
Sep 06, 2024

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September - PR Newswire

Sep 06, 2024
pulisher
Sep 04, 2024

Oncolytic Virus Therapy Market to See Booming Growth 2024-2031 | - openPR

Sep 04, 2024
pulisher
Sep 03, 2024

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September - Barchart

Sep 03, 2024
pulisher
Aug 23, 2024

Oncolytics Biotech Inc. Forecasted to Earn FY2024 Earnings of ($0.29) Per Share (NASDAQ:ONCY) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

HC Wainwright Weighs in on Oncolytics Biotech Inc.'s FY2024 Earnings (TSE:ONC) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

HC Wainwright Analysts Decrease Earnings Estimates for Oncolytics Biotech Inc. (NASDAQ:ONCY) - Defense World

Aug 23, 2024
pulisher
Aug 21, 2024

Oncolytics Biotech (NASDAQ:ONCY) Receives "Buy" Rating from HC Wainwright - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Oncolytics Biotech (NASDAQ:ONCY) Earns “Buy” Rating from HC Wainwright - Defense World

Aug 21, 2024
pulisher
Aug 19, 2024

Thinking about buying stock in Oncolytics Biotech, Nikola Corp, Joby Aviation, Ideanomics, or Better Therapeutics? - GuruFocus.com

Aug 19, 2024
pulisher
Aug 15, 2024

Oncolytics Biotech® to Host Conference Call to Discuss Second Qu - GuruFocus.com

Aug 15, 2024
pulisher
Aug 14, 2024

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer - Longview News-Journal

Aug 14, 2024
pulisher
Aug 14, 2024

Oncolytics Biotech’s Pelareorep Shows Promise in Metastatic Breast Cancer Treatment - Vancity Buzz

Aug 14, 2024
pulisher
Aug 14, 2024

Stock Surge: Oncolytics Biotech, Inc. (ONCY) Closes at 0.91, Marking a -4.06 Increase/Decrease - The Dwinnex

Aug 14, 2024
pulisher
Aug 14, 2024

Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer - Nasdaq

Aug 14, 2024
pulisher
Aug 13, 2024

Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes - Baystreet.ca

Aug 13, 2024
pulisher
Aug 12, 2024

Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates - Barchart

Aug 12, 2024
pulisher
Aug 12, 2024

Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates - Quantisnow

Aug 12, 2024
pulisher
Aug 09, 2024

Advancements In Cancer Therapeutics: What To Expect From The Upcoming 2024 Oncology Conference - MENAFN.COM

Aug 09, 2024
pulisher
Aug 09, 2024

Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected To Reach $7.4 Billion By 2032 - MENAFN.COM

Aug 09, 2024
pulisher
Aug 08, 2024

Virtu Financial LLC Acquires New Stake in Oncolytics Biotech Inc. (NASDAQ:ONCY) - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

Oncolytic Virus Therapy Market Expected to Expand at a Steady - openPR

Aug 07, 2024
pulisher
Aug 07, 2024

ONCY:UN - BNN Bloomberg

Aug 07, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech Announces Equity Distribution Deal - TipRanks

Aug 02, 2024
pulisher
Aug 02, 2024

Earnings call: Oncolytics Biotech outlines progress in cancer trials By Investing.com - Investing.com Australia

Aug 02, 2024
pulisher
Aug 02, 2024

Earnings call: Oncolytics Biotech outlines progress in cancer trials By Investing.com - Investing.com UK

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech Inc (ONCY) Q2 2024 Earnings Call Transcript H - GuruFocus.com

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference - The Malaysian Reserve

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference - StreetInsider.com

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference - BioSpace

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech (TSE:ONC) Stock Passes Above Two Hundred Day Moving Average of $1.47 - Defense World

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference - Financial Times

Aug 02, 2024
pulisher
Aug 02, 2024

Oncolytics Biotech (TSE:ONC) Share Price Crosses Above Two Hundred Day Moving Average of $1.47 - MarketBeat

Aug 02, 2024
pulisher
Aug 02, 2024

Q2 2024 Oncolytics Biotech Inc Earnings Call Transcript - GuruFocus.com

Aug 02, 2024
pulisher
Aug 01, 2024

Oncolytics Biotech Inc. (ONCY) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 01, 2024
pulisher
Aug 01, 2024

Oncolytics Biotech’s Financials Show Asset Decline - TipRanks

Aug 01, 2024
pulisher
Aug 01, 2024

Oncolytics Biotech Advances Cancer Trials with Solid Funding - TipRanks

Aug 01, 2024
pulisher
Aug 01, 2024

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights - PR Newswire

Aug 01, 2024
pulisher
Aug 01, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference - Kilgore News Herald

Aug 01, 2024
pulisher
Jul 30, 2024

Pancreatic Cancer Poised to Become Second Leading Cause of Cancer Death; New Treatment Shows Promise - Vancity Buzz

Jul 30, 2024
pulisher
Jul 30, 2024

Pancreatic Cancer Could Overtake Colorectal Cancer To Become Second Leading Cause Of Cancer Death – Oncolytics Is Working On A Promising Treatment - Nasdaq

Jul 30, 2024
pulisher
Jul 30, 2024

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - Kilgore News Herald

Jul 30, 2024
pulisher
Jul 30, 2024

Pancreatic Cancer Could Overtake Colorectal Cancer To Become Second Leading Cause Of Cancer Death – Oncolytics Is Working On A Promising Treatment - News Channel Nebraska

Jul 30, 2024
pulisher
Jul 25, 2024

Oncolytics Biotech (ONCY) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Jul 25, 2024
pulisher
Jul 25, 2024

Oncolytics Biotech (ONC) Set to Announce Earnings on Thursday - MarketBeat

Jul 25, 2024
pulisher
Jul 25, 2024

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation - Yahoo Finance

Jul 25, 2024
pulisher
Jul 24, 2024

Oncolytics Biotech Inc. - Baystreet.ca

Jul 24, 2024

Oncolytics Biotech Inc Azioni (ONCY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$26.20
price down icon 0.87%
$24.56
price down icon 6.33%
$197.28
price down icon 0.12%
$69.86
price down icon 2.96%
$115.62
price down icon 7.29%
$529.06
price up icon 1.31%
Capitalizzazione:     |  Volume (24 ore):